Jie Wu to Oncogene Proteins, Fusion
This is a "connection" page, showing publications Jie Wu has written about Oncogene Proteins, Fusion.
Connection Strength
1.222
-
Patient-driven discovery and post-clinical validation of NTRK3 fusion as an acquired resistance mechanism to selpercatinib in RET fusion-positive lung cancer. Ann Oncol. 2021 06; 32(6):817-819.
Score: 0.707
-
Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma. Mol Cancer Ther. 2016 10; 15(10):2521-2529.
Score: 0.516